(1) Introduction: The clinical success of dental implants depends on rapid osseointegration, which can be impaired by hydrocarbon contamination and biological aging of titanium surfaces. Chairside plasma surface treatment has emerged as a practical method to restore surface hydrophilicity and enhance early bone–implant integration. (2) Materials and Methods: This retrospective cohort study evaluated 73 plasma-treated implants placed in 47 patients from June 2023 to October 2024. Non-thermal atmospheric pressure plasma was applied immediately before placement using the ACTILINK™ Reborn system. Implant stability was assessed baseline, weekly for the first four weeks, and again at week 8 using resonance frequency analysis (ISQ). Subgroup analyses were conducted according to initial ISQ, jaw location, implant length/diameter, and final insertion torque. (3) Results: All implants healed uneventfully without a stability dip. Mean ISQ increased from 78.97 ± 5.52 at placement to 83.74 ± 4.36 at week 8 (p < 0.001). Implants with lower initial stability demonstrated the greatest relative gains, while those with very high initial stability showed minimal changes. Mandibular and shorter implants demonstrated higher stability gains compared to maxillary and longer fixtures. (4) Conclusions: Chairside plasma surface treatment was associated with progressive ISQ increases during the 8-week healing period. The greatest gains occurred in implants with lower initial stability, while very stable implants showed little change. Stability improvements were also greater in mandibular sites, shorter fixtures, and those with higher insertion torque. These findings are limited to short-term ISQ outcomes and require validation in prospective controlled trials with standardized protocols.

Background/Objectives: Vertical ridge augmentation remains a challenging procedure in alveolar bone reconstruction, with existing techniques often limited by surgical complexity, graft instability, and high resorption rates. This study evaluates the clinical and histological outcomes of a novel vertical ridge augmentation technique using a wide-head tenting pole screw (WHTPS) combined with sticky bone graft material. Methods: Five patients with vertical bone deficiencies (6–10 mm) in the maxilla or mandible underwent augmentation using a single WHTPS (rectangular or round wide-head type). Sticky bone was prepared using autologous tooth bone, allografts, or xenografts, combined with fibrin glue and covered with concentrated growth factor (CGF) membranes and/or resorbable collagen membranes. After 5–6 months of healing, the WHTPS was removed, and bone biopsies were taken for histological analysis. Results: Radiographic and histological evaluations confirmed successful ridge augmentation in all cases. Newly formed bone ranged from 21.2% to 57.5%. All patients proceeded to implant placement without complications. Radiographic, clinical, and histological assessments consistently showed that new bone formation extended up to the level of the screw head, indicating complete vertical fill of the augmented space. Histology showed well-integrated, mineralized bone with no signs of inflammation. The wide-head tenting pole screw was observed to support stable space maintenance and facilitate surgical handling and favorable outcomes in vertical ridge augmentation. Conclusions: In this case series, a single wide-head tenting pole screw appeared sufficient to maintain space and resist soft tissue pressure in wide alveolar bone defects during healing. This case series suggests that the wide-head tenting pole screw technique may be a feasible option for managing severe alveolar bone deficiencies.

Dong-Seok Sohn, Ji-Rak Kim, Hyung-Gyun Kim, Hyun-Suk Choi, Yong-Suk Moon. JKAOMS 2021;47:269-78. https://doi.org/10.5125/jkaoms.2021.47.4.269

Introduction: Although significant advancements have been made in surgical techniques for reconstructing severely resorbed alveolar bone, achieving predictable regeneration remains a considerable challenge. Many conventional ridge augmentation methods require extended edentulous healing periods and multiple surgical interventions. This clinical study introduces a simplified approach to advanced ridge augmentation using a wide-head tent-pole screw (WHTPS), aimed at enhancing procedural efficiency and achieving predictable clinical outcomes. Material and Methods: Thirteen patients with severely vertically resorbed mandibular segments or completely edentulous alveolar ridges—each presenting with a minimum vertical bone defect of 5 mm—were included in this study. A single WHTPS was placed at the most severe bone defect site, followed by bone grafting and coverage with a resorbable membrane. Postoperative panoramic radiographs were taken immediately after surgery and again on the day of WHTPS removal, following a healing period of 3 to 6 months. An additional follow-up radiograph was obtained after final prosthesis placement, with an average follow-up period of 5.5 months, to assess changes in the augmented bone. Patients were monitored clinically for a period ranging from 8 to 20 months (mean: 14.9 months). Results: The average vertical bone gain immediately after surgery was 8.86 mm (SD ± 2.59 mm), while an average bone resorption of 1.49 mm (17.79%) was observed during the follow-up period. Conclusions: A single WHTPS effectively stabilized the graft material in cases of severe alveolar bone loss, thereby preventing its resorption and displacement. Further clinical studies are necessary to validate its long-term effectiveness.

Alveolar bone loss due to trauma, extraction, or periodontal disease often requires bone grafting prior to implant placement. Although human allograft bone is widely used as an alternative to autograft, it has limited osteoinductive potential and a prolonged healing time. Mesenchymal stem cell–conditioned media (MSC-CM), rich in paracrine factors, has emerged as a promising adjunct to enhance bone regeneration. This study evaluated the regenerative effect of MSC-CM combined with human allograft bone in a rabbit calvarial defect model. Bilateral 8 mm defects were created in eight rabbits. Each animal received a human allograft alone (HB group) on one side and an allograft mixed with MSC-CM (HB+GF group) on the other. Histological and histomorphometric analyses were performed at 2 and 8 weeks postoperatively. Both groups showed new bone formation, but the HB+GF group demonstrated significantly greater bone regeneration at both time points (p < 0.05). New bone extended into the defect center in the HB+GF group. Additionally, greater graft resorption and marrow formation were observed in this group at 8 weeks. These findings suggest that MSC-CM enhances the osteogenic performance of human allograft bone and may serve as a biologically active adjunct for bone regeneration.

When placing dental implants, xenografts are most commonly used clinically to compensate for the insufficient bone volume of patients. However, xenografts have limitations including low osteoinductive capacity and prolonged healing time. This study aimed to determine whether non-thermal plasma treatment could enhance the regenerative performance of bovine cancellous bone graft (SANTA-OSS^®) in a rabbit calvarial defect model. Twenty-four adult male New Zealand white rabbits received bilateral 8 mm critical-size calvarial defects. One defect was filled with untreated SANTA-OSS (control) and the contralateral defect with plasma-treated SANTA-OSS using the ACTILINK™ Reborn device. Animals were sacrificed at 2, 4, and 8 weeks (n = 8 per group) for histomorphometric analysis. The plasma-treated group showed significantly higher new bone area (14.12 ± 0.69%, 18.93 ± 0.68%, and 32.72 ± 0.61% at 2, 4, and 8 weeks) than the control at all time points (p < 0.05). In addition, the experimental group exhibited accelerated graft resorption, larger bone marrow area, greater blood vessel area, and more TRAP-positive osteoclasts compared with the control (p < 0.05). Within the limitations of this study, non-thermal plasma treatment significantly enhanced new bone formation and promoted favorable graft remodeling, while also accelerating graft resorption, increasing bone marrow area, and improving vascularization. These findings suggest that simple chairside plasma activation can improve the regenerative performance of xenografts.